Study to Characterize the Pharmacokinetics of a Single Dose of SC Abatacept 125 mg Using the BD Autoinjector or the Prefilled Syringe

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2013
The primary purpose of the protocol is to describe the pharmacokinetics of a single dose of Abatacept 125 mg in Rheumatoid Arthritis patients delivered via the autoinjector device or the approved prefilled syringe.
Epistemonikos ID: a680418fb4d54c9953e9a25634005c857180dca6
First added on: Mar 23, 2022